Market revenue in 2024 | USD 3,057.0 million |
Market revenue in 2030 | USD 5,467.3 million |
Growth rate | 10.2% (CAGR from 2024 to 2030) |
Largest segment | Innovative |
Fastest growing segment | Generic |
Historical data covered | 2018 - 2023 |
Base year for estimation | 2024 |
Forecast period covered | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Innovative, Generic |
Key market players worldwide | Piramal Pharma Solutions, Lonza Group Ltd, Catalent Inc, Pfizer Inc, AbbVie Inc, Dr Reddy's Laboratories Ltd ADR, VxP Pharma, Gentec Pharmaceutical Group, CordenPharma, Curia |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to high potency api contract manufacturing market will help companies and investors design strategic landscapes.
Innovative was the largest segment with a revenue share of 72.37% in 2024. Horizon Databook has segmented the North America high potency api contract manufacturing market based on innovative, generic covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America high potency api contract manufacturing market , including forecasts for subscribers. This continent databook contains high-level insights into North America high potency api contract manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account